Trial intelligence / Profile preview

Dulera vs Advair in Persistent Asthma

NCT00424008Phase 3Completed

Sponsor
Organon & Co.
Start
Apr 2007
Primary completion
Nov 2008
Modality
Orthosteric Ligands
01

Overview

Phase 3, randomised, single-blind trial of mometasone furoate + formoterol fumarate in asthma (2 arms), sponsored by Organon & Co. Primary endpoint: Area Under the Curve From 0 to 12 Hours of the Change From Baseline in Forced Expiratory Volume in One Second. Started Apr 2007; status: completed.

02

Drugs

mometasone furoate + formoterol fumarate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00424008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00424008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call